Skip to main content
. 2021 Dec 6;5(23):5098–5106. doi: 10.1182/bloodadvances.2021004710

Figure 2.

Figure 2.

PFS per IRF in the ITT population. (A) PFS for patients with MF. (B) PFS for patients with C-ALCL. PFS is defined in Figure 1. Patients were censored at last disease assessment if they withdrew consent, were lost to follow-up, or discontinued treatment because of undocumented disease progression after the last adequate disease assessment.